Emergency department visits due to coronary artery disease during COVID-19 in Finland: A register-based study

Mikko Uimonen1, Ville Ponkilainen1, Ilari Kuitunen2,3

  • 1Department of Surgery, Central Finland Hospital Nova, Finland.

Insights

The COVID-19 pandemic reduced cardiology referrals and acute coronary syndrome visits but increased emergency visits for chronic coronary artery disease in Finland. This highlights impacts on cardiovascular care access during health crises.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly disrupted healthcare services globally.
  • Understanding its impact on chronic disease management, such as coronary artery disease (CAD), is crucial.

Purpose of the Study:

  • To investigate the effects of restricted healthcare availability during the COVID-19 pandemic on CAD treatment in Finland.
  • To analyze changes in cardiology referrals, emergency department visits, and hospitalizations for CAD.

Main Methods:

  • A multi-center study analyzing data from three Finnish hospitals (2017-2020).
  • Collected data included referrals (n=81,008), emergency department (ED) visits (n=10,001), and hospitalizations (n=8654) for CAD.
  • Incidences were calculated per 100,000 persons, comparing 2020 to the 2017-2019 reference period using incidence rate ratios (IRR).

Main Results:

  • Referrals to cardiology units decreased by 17% (IRR=0.83) from March to May 2020.
  • Emergency department visits for acute coronary syndrome decreased overall (2-14% lower annually).
  • Emergency department visits for chronic CAD significantly increased in April and May 2020 (IRR=1.49 and 1.57, respectively) and remained elevated, showing a 17% annual increase (IRR=1.17).

Conclusions:

  • The COVID-19 pandemic led to reduced cardiology referrals and acute coronary syndrome presentations.
  • A notable increase in emergency department visits for chronic CAD suggests delayed or altered care-seeking behaviors.
  • These findings underscore the significant impact of pandemic-related healthcare restrictions on the management of coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
405
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
80
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
510
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
54